Skip to content

Svenningsson lab

Translational Research on Neuropharmacology and Movement Disorders

  • Home
  • News
  • Research
    • Pre-Clinical
      • P11 and G protein-coupled receptor function & pharmacology
      • Proteinopathies
    • Clinical
      • Clinical trials and Biomarkers in Parkinsonism
      • Ataxia, spastic paraparesis, chorea and other movement disorders
      • The role of glycemic control in Parkinson’s disease
  • Publications
  • People
    • Core Pre-Clinical Group
    • Core Clinical Group
    • Join our team
    • Alumni
    • Lab Group photos
  • Funding
  • Outreach
  • För Patienter
  • Contact
Posted on 30 March 202525 April 2025 by Anderson Camargo

Aligning Science Across Parkinson’s (ASAP) – CRN 2025

Postdoc Daniel Dautan at the ASAP 2025 conference.

CategoriesUncategorized

Post navigation

Previous PostPrevious New paper in Neuropsychopharmacology regarding novel molecular mechanisms mediating clozapine behavioral effects.
Next PostNext Visit and talk from Professor Per Svenningsson at Professor Bryan Roth Lab

Postal Address

Karolinska Institutet
NKS, Bioclinicum
Visionsgatan 4
J5:20 Neuro- Svenningsson
Solna, 171 64

Telephone

+46 851774614

Our Karolinska Institute webpage

https://ki.se/en/cns/per-svenningssons-research-group-0

 

Proudly powered by WordPress